Caribou Biosciences (CRBU) EBT Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2,817.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,558.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -683.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,688.00 |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - | 72,739.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72,739.00 |
| Dec 31, 2025 | 114,972.00 |
| Sep 30, 2025 | 55,165.00 |
| Jun 30, 2025 | -52,815.00 |
| Mar 31, 2025 | 7,011.00 |
| Dec 31, 2024 | -81,936.00 |
| Sep 30, 2024 | -182,739.00 |
| Jun 30, 2024 | -38,049.00 |
| Mar 31, 2024 | -100,534.00 |
| Dec 31, 2023 | -22,411.00 |
| Sep 30, 2023 | 74,158.00 |
| Jun 30, 2023 | -19,709.00 |
| Mar 31, 2023 | -10,575.00 |
| Dec 31, 2022 | -11,865.00 |
| Sep 30, 2022 | -27,604.00 |
| Jun 30, 2022 | 29,136.00 |
| Mar 31, 2022 | 4,693.00 |
| Dec 31, 2021 | 82,061.00 |
| Sep 30, 2021 | 15,258.00 |
| Jun 30, 2021 | -94,691.00 |
| Mar 31, 2021 | -18,290.00 |